MedTrace Logo

Cardiovascular Disease in FH Heterozygous

NCT01783405 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1100

Last updated 2014-06-10

No results posted yet for this study

Summary

The objective of this project is to establish the current prevalence of cardiovascular disease in adult subjects suffering from genetically diagnosed HF, and to know the impact that drug treatment has course in cardiovascular disease when compared with that of their affected parents with a much longer period of exposure to hypercholesterolemia

Conditions

  • Familial Hypercholesterolemia

Sponsors & Collaborators

  • Hospital Miguel Servet

    collaborator OTHER

  • Universidad de Zaragoza

    collaborator OTHER

  • Sociedad Española de Arteriosclerosis

    lead OTHER

Principal Investigators

  • Fernando Civeira, MD, PhD · Universidad de Zaragoza

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01783405 on ClinicalTrials.gov